BRPF1 inhibitor GSK6853 inhibits NSCLC cell proliferation via the JAK2/STAT3/CCNA2 axis to induce cell cycle arrest.

Invest New Drugs · 2025 · PMC12634795 · PMID 41160097

Europe PMC DOI

hedged sentence

0.0890

closest p · 1.8× alpha

0.0890

boldest claim

The sentences

showed a trendP = 0.089so close (0.05 < p ≤ 0.1)

5 B) and showed a trend toward shorter disease-free survival (HR = 1.3, log-rank P = 0.089; Fig. 5 C).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.